Commentary on new xenobiotic immunosuppressants for transplantation:  Where are we, how did we get here, and where are we going?
Laboratory for Transplantation Immunology, Department of Cardiothoracic Surgery, Stanford University Medical School, CA.
R E
RE
Morris
D001327:Autoimmune Diseases / Q000188:drug therapy; D004341:Drug Evaluation / Q000379:methods; D005544:Forecasting; D006084:Graft Rejection / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D007165:Immunosuppression Therapy / Q000639:trends*; D007166:Immunosuppressive Agents / Q000145:classification / Q000494:pharmacology; D014183:Transplantation, Heterologous / Q000639:trends; D015262:Xenobiotics / Q000627:therapeutic use*